Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Germany-based Merck has started construction work at its Darmstadt site on a production plant for the manufacture of inorganic salts. This will increase capacity of the company by around 50% compared to the production lines currently being used.
Subscribe to our email newsletter
The company is investing around E30m in planning, developing and constructing the plant, which will produce active ingredients and excipients, products for use in biopharmaceutical production processes, additives for the food industry and laboratory reagents.
The company said that the plant is scheduled to begin operation in mid-2011, when nearly 70 employees in inorganic chemical production will move to the new facilities.
Klaus Bischoff, head of the performance and life science chemicals division at Merck, said: “The cornerstone has been laid for a key investment in the future. As a supplier of key technologies, we want to grow along with our customers in the pharmaceutical and biopharmaceutical industries.
“This expansion of capacity and modernisation is our response to the growing global demand for and high requirements placed on quality and product safety for final pharmaceutical and biopharmaceutical formulations. At the same time, the new plant is a strong commitment to Darmstadt as a Merck chemical production site.”